From: Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study
Index group with oedema (n = 7)
Reference group without oedema (n = 7)
P value
Cmax (IU/ml)
0.15 ± 0.02
0.14 ± 0.02
0.34
AUC(0–24 h) (h·IU/ml)
1.50 ± 0.31
1.15 ± 0.25
0.31